•  An W, Huang Y, Chen S, Teng T, Shi Y, Sun Z, Xu Y. Mechanisms of Rhizoma Coptidis against type 2 diabetes mellitus explored by network pharmacology combined with molecular docking and experimental validation. Sci Rep. 2021 Oct 21;11(1):20849.

•  An W, Huang Y, Chen S, Teng T, Liu J, Xu Y. Efficacy and safety of Huangkui capsule for diabetic nephropathy: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021 Oct 22;100(42):e27569.

•  Guo Q, Xu Y, Li J, An W, Luo D, Huang C, Huang Y. Explore the Effect and Target of Liraglutide on Islet Function in Type 2 Diabetic Rats by miRNA Omics Technology. Diabetes Metab Syndr Obes. 2021 Sep 1;14:3795-3807.

•  Sun Z, Xu Y, An W, Bi S, Xu S, Zhang R, Cong M, Chen S. Mining Important Herb Combinations of Traditional Chinese Medicine against Hypertension Based on the Symptom-Herb Network Combined with Network Pharmacology. Evid Based Complement Alternat Med. 2022 Mar 22;2022:5850899.

•  安文蓉,徐云生,黄延芹.基于数据挖掘的健脾消渴方治疗2型糖尿病临床特点与规律分析[J].中华中医药学刊,2020,38(02):191-194.

•  安文蓉,徐云生,黄延芹.mTORC1在糖尿病致病机理探析[J].中华中医药学刊,2019,37(01):92-95.

•  黄延芹,安文蓉,徐灿坤,徐亮,徐云生.糖异平通过TXNIP/miR-204/MAFA信号通路调控胰岛β细胞功能治疗糖耐量减低机制探讨[J].时珍国医国药,2021,32(04):922-925.

•  安文蓉,陈守强,徐云生.徐云生治疗甲状腺疾病用药规律的varclus聚类分析[J].世界中西医结合杂志,2018,13(01):18-21.

•  安文蓉,徐云生,陈守强.基于多维宏观量化方法的左归丸及左归饮的组方规律[J].世界中医药,2018,13(09):2340-2345.

•  安文蓉,黄延芹,王经武,徐云生.徐云生治疗甲状腺功能亢进症用药规律的Logistic回归分析[J].实用中西医结合临床,2018,18(01):133-135.

•  谭超,安文蓉,刘娟,崔玉娇,朱青,谢瑞,于鹰.大柴胡汤中柴胡、大黄不同配比对抗炎镇痛作用的影响[J].西部中医药,2016,29(03):8-10.